Delivery Order SPE2DB22D2206-SPE2DB25FGP58
Award Date
4/16/25
Potential Completion Date
5/7/25
Potential Value
$18K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ONIVYDE 43 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $10,691.34 and a performance period ending on May 9, 2025. The contract is a firm-fixed-price delivery order, and it is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ONIVYDE 43 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $5,345.67 and a performance period through June 3, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,056.20 firm fixed-price delivery order is for the supply of 4566166957 ONIVYDE 43 MG/10 ML VIAL 10ML, with a completion date of November 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the pharmaceutical product ONIVYDE 43 MG/10 ML VIAL 10ML. The delivery order has a firm fixed price of $10,112.40 and a period of performance through April 29, 2024. Amerisourcebergen Drug Corp serves as a prime contractor to the DLA, providing a wide range of pharmaceutical products and medical supplies in support of...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $15,168.60 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ONIVYDE 43 MG/10 ML VIAL 10ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. The $8,427.00 firm-fixed price contract is for the supply of ONIVYDE 43 MG/10 ML VIAL 10ML, a pharmaceutical product, with a period of performance through May 28, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. government, particularly the Department of Defense (DoD) and Department of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (doing business as Amerisourcebergen), to supply ONIVYDE 43 MG/10 ML VIAL 10ML, a specialty pharmaceutical product, with a ceiling value of $16,854.00 and a period of performance through April 10, 2024. This delivery order was placed under an existing Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp,...
This federal contract award is for the delivery of ONIVYDE 43 MG/10 ML VIAL 10ML to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on April 1, 2025, with a ceiling value of $7,127.56 and a completion date of April 22, 2025. The contract is a Delivery Order under a Firm Fixed Price contract type. The award is not associated with a set-aside designation. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,631.26, is for the delivery of POLIVY 140 MG VIALS, a medical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of OPDIVO 240 MG/24 ML VIAL 24ML. The contract has a ceiling value of $14,906.79 and is a firm fixed-price delivery order, with an ultimate completion date of June 12, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...